Last Price | 27.54 | Max Price | 51.20 |
Min Price | 25.97 | 1 Year return | -43.02 |
Avg. Target | 33.29 | Expected Return | 20.86 % |
Sector | Basic Materials | Subsector | Chemicals |
Sell | 0 | Rating |
![]() ![]() ![]() |
Hold | 5 | Concensus |
![]() ![]() |
Buy | 3 | ||
Annual report 2016 |
Bayer AG is active in the fields of health care, nutrition and innovative materials. The Bayer produces approximately 5,000 products in the fields of health care, nutrition and high-tech materials. Bayer AG’s stocks are traded on the Deutsche Börse and the company is a component of the DAX30-index (ISIN: DE0005752000/ Symbol: BAY).
Contact info:Street: Building W 11Zip Code: D-51368 LeCity: LeverkusenCountry: GermanyPhone: 49-214-30-81013Email: alexander.rosar@bayer.comWebsite: www.bayer.deCEO: Marijn DekkersCFO: Werner Baumann
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 43,545 | 1,133,095 | 3.84 % |
2020 | 41,400 | 1,124,179 | 3.68 % |
2021 | 44,081 | 1,549,884 | 2.84 % |
2022 | 50,739 | 805,600 | 6.30 % |
2023 | 0 | 0 | 0.00 % |
Analysts count on sales decrease Bayer
Analysts foresee more revenue Bayer, quite high dividend
Analysts expect over 2021 decreasing revenue Bayer, relatively high dividend
Analysts foresee less revenue Bayer, high dividend yield
Analysts expect over 2020 decreasing revenue Bayer, huge dividend
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Bayer, the stock lost around 16 percent. Bayer' stock rose the past 5 years at around 110 percent. Bayer's revenues between 2011 and 2015 were relatively stable and moved between 39,76 billion euros and 46,32 billion euros. Bayer's net results between 2011 and 2015 were quite unstable and moved between 2,47 billion euros and 4,02 billion euros.
The head office of Bayer is situated in Leverkusen. Bayer is mostly active in the chemical sector. Marijn Dekkers manages the company as a CEO. Bayer has Werner Baumann as CFO financial responsible for the company. The global chemical companies gained around 72 percent worldwide over the last 10 years. Since 2011 the sector is 20 percent higher and over the past year minus 72 percent.
Over the past 5 years the German company paid out dividends. Over the past 5 years the stock delivered an average dividend return of 10,4 percent. Over the past 5 years the company raised it's dividends each year. Based on the raising dividend payments Bayer can be seen as a kind of dividend aristocrat.
The German company had ultimo 2015 approximately 118,89 thousand employees on it's payroll.
At the end of 2015 the German company's balance sheet was worth 73,92 billion euros. At the end of 2015 the total debt positon equaled 49,65 billion euros. This is around 67,17 percent of the total balance sheet. At the end of 2015 the chemical company's stock was traded with a price/earnings-ratio 20. So the stock' value was 20 times the 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the German stock can be seen as a value stock.
At the end of 2015 the chemical company's market size (her number of outstanding share times the stock price) equaled around 92 billion euros. At the end of 2015 the German company had around 826,95 million stocks listed.
All of Bayer's annual reports are stored here. More information about Bayer can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
46,324
|
46,769
|
35,015
|
39,586
|
43,545
|
41,400
|
Costs |
42,214
|
42,238
|
27,679
|
37,891
|
39,454
|
51,895
|
Profit |
4,110
|
4,531
|
7,336
|
1,695
|
4,091
|
-10,495
|
Margin of profit |
8.87
|
9.69
|
20.95
|
4.28
|
9.39
|
-25.35
|
ROI |
16.94
|
14.94
|
19.93
|
3.69
|
8.66
|
-34.38
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
24,265
|
30,333
|
36,801
|
45,977
|
47,253
|
30,523
|
Debt |
49,652
|
51,905
|
38,286
|
80,755
|
78,921
|
86,281
|
Total assets |
73,917
|
82,238
|
75,087
|
126,732
|
126,174
|
116,804
|
Solvency |
32.83
|
36.88
|
49.01
|
36.28
|
37.45
|
26.13
|
Cash |
2,131
|
5,424
|
9,098
|
5,002
|
5,404
|
11,883
|
Cashflow |
6,895
|
9,092
|
8,134
|
7,918
|
8,187
|
4,896
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.14
|
0.18
|
0.21
|
0.10
|
0.10
|
0.06
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
113.96
|
97.55
|
102.35
|
60.56
|
72.81
|
Eps |
5.36
|
8.29
|
1.80
|
4.17
|
-10.68
|
Price/earnings-ratio |
21.26
|
11.77
|
56.86
|
14.52
|
-2.58
|
Dividend |
2.66
|
2.76
|
2.80
|
2.80
|
2.00
|
Dividend % |
2.33 %
|
2.83 %
|
2.74 %
|
4.62 %
|
7.26 %
|
Payout % |
0.50
|
0.33
|
1.56
|
0.67
|
-0.19
|
Book value |
36.10
|
43.79
|
49.30
|
48.10
|
31.07
|
Market to book |
0.32
|
0.45
|
0.48
|
0.79
|
1.13
|
Cashflow per stock |
10.82
|
9.68
|
8.49
|
8.33
|
4.98
|
Stocks |
840
|
840
|
933
|
982
|
982
|
Market Cap |
95.761.58
|
81.972.12
|
95.446.70
|
59.495.60
|
27.055.96
|
Date
|
Price
|
---|---|
28 Aug 2024
|
27.54
|
26 Aug 2024
|
27.56
|
23 Aug 2024
|
27.71
|
11 Aug 2024
|
25.97
|
07 Aug 2024
|
26.12
|
05 Aug 2024
|
26.95
|
01 Aug 2024
|
27.50
|
30 Jul 2024
|
27.44
|
26 Jul 2024
|
27.53
|
23 Jul 2024
|
27.31
|
16 Jul 2024
|
26.39
|
10 Jul 2024
|
26.13
|
09 Jul 2024
|
26.06
|
04 Jul 2024
|
26.23
|
02 Jul 2024
|
26.15
|
26 Jun 2024
|
26.15
|
21 Jun 2024
|
28.06
|
19 Jun 2024
|
28.06
|
14 Jun 2024
|
28.06
|
11 Jun 2024
|
28.06
|
01 Jun 2024
|
28.06
|
31 May 2024
|
28.06
|
27 May 2024
|
28.06
|
21 May 2024
|
28.06
|
15 May 2024
|
28.06
|
10 May 2024
|
28.06
|
07 May 2024
|
28.06
|
01 May 2024
|
27.35
|
22 Apr 2024
|
26.25
|
18 Apr 2024
|
26.25
|